The U.S. Food and Drug Administration (FDA) on Monday recommended that the H1N1 (swine flu) strain be added to next year’s seasonal flu vaccine, “putting an end to separate shots deployed against the pandemic,” Bloomberg reports. The FDA committee voted unanimously to make the H1N1 strain one of the three strains included in the shot, according to the news service. “The panelâ€™s recommendations are routinely adopted and used to guide vaccine manufacturers,” Bloomberg writes (Randall, 2/22).
Pneumonia & Flu
The WHO is recommending the H1N1 (swine flu) virus be added to the regular flu vaccine for the Northern Hemisphere’s 2010-2011 regular flu season, the Associated Press reports (2/18).
Lancet Comment Examines Interconnectedness Of Global Health, Public Health “Global health and public health are indistinguishable,” according to a Lancet Comment that examines the interconnectedness of the fields. “Yet global health is still often perceived as international aid, technologies, and interventions flowing from the wealthier countries of the global north…
The WHO will convene a meeting of its emergency committee later this month to assess whether H1N1 (swine flu) has peaked, Keiji Fukuda, the special adviser to the WHO’s director general for pandemic influenza said Thursday, Bloomberg reports. “While the flu continues to spread in parts of the world, notably northern Africa, eastern Europe and eastern Asia, infection activity is declining, [Fukuda] said,” according to Bloomberg (Serafino, 2/11).
U.S. Isn’t Backing Off Its Commitments To International Health President Barack Obama’s FY2011 budget demonstrates that the U.S. “isn’t backing off its commitment to aid other nations,” according to a VOA News editorial by the U.S. government. “Specifically, President Obama is proposing to boost U.S. efforts to promote health and…
As the number of new H1N1 (swine flu) infections worldwide drops, U.S. health officials on Friday cautioned the virus continues to circulate and can still be deadly, Reuters reports. According to the WHO, H1N1 remains the dominant strain worldwide, but there are reports of the recent emergence of the seasonal flu in Africa and China, according to the news agency.
The New York Times examines the WHO’s role as “clearinghouse” for getting H1N1 (swine flu) vaccines to lower income nations. Though H1N1 has died down in North America and many wealthier nations “are trying to get rid of their [vaccine] surpluses,” the virus continues to circulate in regions of North Africa, Central Asia and Eastern Europe, according to the newspaper.
The FDA on Monday said it’s entering into a collaboration with the nonprofit group PATH “to speed creation of a pneumococcal vaccine for children in developing nations,” United Press International reports (2/1).
The Canadian government on Thursday announced the country would donate five million doses of H1N1 vaccines to the WHO from the country’s current surplus, the Canadian Press reports (Branswell, 1/28). “[T]he donation will help the Geneva-based international body in its efforts to redistribute the vaccine to developing countries that couldn’t afford their own supplies,” the Globe and Mail reports (Alphonso, 1/28).
Biovac Institute, a South African vaccine maker, said Monday that it is working with other major pharmaceutical firms to increase its annual capacity sevenfold to 35 million doses by 2013, Reuters reports. Morena Makhoana, the company’s deputy chief executive, said that 25 million of those doses will remain in Africa.